Nicole Onetto

Nicole M.
Onetto is currently an Independent Non-Executive Director at Basilea Pharmaceutica AG since 2017, an Independent Director at Bolt Biotherapeutics, Inc. since 2021, and a Director at CDR-Life AG since 2022.
Former roles include Senior Director-Medical Affairs at Bristol Myers Squibb Co. from 1991 to 1997, Independent Director at ImmunoGen, Inc. from 2011 to 2016, Director at YM BioSciences, Inc. from 2014 to 2015, Independent Director at Sierra Oncology, Inc. from 2015 to 2019, Independent Director at Sunesis Pharmaceuticals, Inc. from 2019 to 2021, Deputy Director & Chief Scientific Officer at Ontario Institute for Cancer Research from 2013 to 2016, Director at NBE-Therapeutics AG from 2017 to 2021, Independent Director at Viracta Therapeutics, Inc. from 2021 to 2023, Senior Vice President-Medical Affairs at Gilead Sciences, Inc. in 2001, Chief Medical Officer & Executive Vice President at OSI Pharmaceuticals, Inc. from 2002 to 2005, Vice President-Medical Affairs at NeXstar Pharmaceuticals, Inc. from 1997 to 1999, and Chief Medical Officer & Senior Vice President at ZymoGenetics, Inc. from 2005 to 2009.
Education includes graduate studies at the University of Montréal and undergraduate and doctorate degrees from Université de Paris 5 René Descartes.